Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen's License of Harvard Chemistry Topped Most-Read GenomeWeb Daily News Stories Last Week

NEW YORK (GenomeWeb News) - What are GenomeWeb News subscribers reading? Below are the five most-read articles for the five-day period ended Friday, Dec. 14.
 
1. Invitrogen Licenses Harvard's Click Chemistry Technology for Cell-Based Assays (from Dec. 10)
 
2. Gene Logic Shareholders OK Sale of Genomic Business, Name Change (from Dec. 11)
 
3. NIH to Grant $43M in FY 2009 Under Shared Instruments Program (from Dec. 10)
 
4. FDA Relabels Carbamazepine to Recommend Genetic Test for Risk of Skin Reactions (from Dec. 12)
 
5. Harvard Bio Gets $5 Per Share Buyout Offer from Investor (from Dec. 14)
The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.